15515776

Source:http://linkedlifedata.com/resource/pubmed/id/15515776

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0012634, umls-concept:C0042164, umls-concept:C0205269, umls-concept:C0666743, umls-concept:C0678226
pubmed:issue	4 Suppl 34
pubmed:dateCreated	2004-11-1
pubmed:abstractText	To report 4 cases of refractory panuveitis due to Behçet's disease treated with a novel therapy: infliximab.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8308521
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Immunologic Factors, http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:issn	0392-856X
pubmed:author	pubmed-author:BadelonII, pubmed-author:BodaghiBB, pubmed-author:CassouxNN, pubmed-author:FainOO, pubmed-author:HuongD L TDL, pubmed-author:LeHoangPP, pubmed-author:PietteJ-CJC, pubmed-author:Sablé-FourtassouRR, pubmed-author:WechslerBB
pubmed:issnType	Print
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	S14-6
pubmed:meshHeading	pubmed-meshheading:15515776-Adolescent, pubmed-meshheading:15515776-Adult, pubmed-meshheading:15515776-Antibodies, Monoclonal, pubmed-meshheading:15515776-Antirheumatic Agents, pubmed-meshheading:15515776-Behcet Syndrome, pubmed-meshheading:15515776-Child, pubmed-meshheading:15515776-Drug Resistance, Multiple, pubmed-meshheading:15515776-Drug Therapy, Combination, pubmed-meshheading:15515776-Female, pubmed-meshheading:15515776-Humans, pubmed-meshheading:15515776-Immunologic Factors, pubmed-meshheading:15515776-Immunosuppressive Agents, pubmed-meshheading:15515776-Infusions, Intravenous, pubmed-meshheading:15515776-Male, pubmed-meshheading:15515776-Panuveitis, pubmed-meshheading:15515776-Recurrence, pubmed-meshheading:15515776-Retrospective Studies, pubmed-meshheading:15515776-Treatment Outcome, pubmed-meshheading:15515776-Tumor Necrosis Factor-alpha
pubmed:articleTitle	Infliximab in refractory uveitis due to Behçet's disease.
pubmed:affiliation	Department of Internal Medicine, Hôpital Pitié-Salpêtrière, Paris, France.
pubmed:publicationType	Journal Article, Case Reports